文献速递临床试验与 GCP流行病学与生物统计

VITAL Start视频干预促进马拉维HIV孕妇抗逆转录病毒治疗依从性与保留的随机对照试验方案

The Video intervention to Inspire Treatment Adherence for Life (VITAL Start): protocol for a multisite randomized controlled trial of a brief video-based intervention to improve antiretroviral adherence and retention among HIV-infected pregnant women in Malawi.
PubMed 文献 · Trials · 2020-02-19

本研究为多中心平行组随机对照试验,纳入892名尚未开始抗逆转录病毒治疗的HIV感染孕妇,随机分配至标准护理组或VITAL Start视频干预组。主要结局为开始治疗12个月后病毒载量<1000拷贝/毫升的保留与依从复合指标,同时评估行为依从性、心理社会影响、资源利用及成本效果。

要点

  • VITAL Start是简短设施内视频干预,旨在提升HIV孕妇ART保留与依从性。
  • 主要结局为12个月时病毒载量<1000 copies/ml的复合保留与依从指标。
  • 试验将评估实施情况和成本效果,样本量892名孕妇。

核心结论

  • 该试验旨在评估VITAL Start视频干预对HIV感染孕妇ART保留和依从性的有效性与实施效果。

研究设计与样本

  • 多中心平行组随机对照试验,纳入892名尚未开始ART的HIV感染孕妇,随机分配至标准护理或VITAL Start组。

关键数值与推荐

  • 主要结局为开始ART后12个月病毒载量<1000 copies/ml的保留与依从复合指标。
  • 次要结局包括自我报告依从性、药房续药、替诺福韦二磷酸浓度、心理社会影响和资源利用。

临床怎么用

  • 若有效,VITAL Start可作为可规模化实施的设施内视频干预,优化HIV孕妇ART保留与依从。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Improving maternal antiretroviral therapy (ART) retention and adherence is a critical challenge facing prevention of mother-to-child transmission (PMTCT) of HIV programs. There is an urgent need for evidence-based, cost-effective, and scalable interventions to improve maternal adherence and retention that can be feasibly implemented in overburdened health systems. Brief video-based interventions are a promising but underutilized approach to this crisis. We describe a trial protocol to evaluate the effectiveness and implementation of a standardized educational video-based intervention targeting HIV-infected pregnant women that seeks to optimize their ART retention and adherence by providing a VITAL Start (Video intervention to Inspire Treatment Adherence for Life) before committing to lifelong ART. METHODS: This study is a multisite parallel group, randomized controlled trial assessing the effectiveness of a brief facility-based video intervention to optimize retention and adherence to ART among pregnant women living with HIV in Malawi. A total of 892 pregnant women living with HIV and not yet on ART will be randomized to standard-of-care pre-ART counseling or VITAL Start. The primary outcome is a composite of retention and adherence (viral load < 1000 copies/ml) 12 months after starting ART. Secondary outcomes include assessments of behavioral adherence (self-reported adherence, pharmacy refill, and tenofovir diphosphate concentration), psychosocial impact, and resource utilization. We will also examine the implementation of VITAL Start via surveys and qualitative interviews with patients, partners, and health care workers and conduct cost-effectiveness analyses. DISCUSSION: This is a robust evaluation of an innovative facility-based video intervention for pregnant women living with HIV, with the potential to improve maternal and infant outcomes. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03654898. Registered on 31 August 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Kim MH, Tembo TA, Mazenga A, et al. The Video intervention to Inspire Treatment Adherence for Life (VITAL Start): protocol for a multisite randomized controlled trial of a brief video-based intervention to improve antiretroviral adherence and retention among HIV-infected pregnant women in Malawi. Trials. 2020. PMID: 32075677. doi:10.1186/s13063-020-4131-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。